259 related articles for article (PubMed ID: 30496814)
1. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen.
Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H
Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814
[TBL] [Abstract][Full Text] [Related]
2. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
[TBL] [Abstract][Full Text] [Related]
3. Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress.
Dong C; Zhang L; Sun R; Liu J; Yin H; Li X; Zheng X; Zeng H
Sci Rep; 2016 Nov; 6():36860. PubMed ID: 27845427
[TBL] [Abstract][Full Text] [Related]
4. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
[TBL] [Abstract][Full Text] [Related]
5. Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.
Zheng X; Ma W; Sun R; Yin H; Lin F; Liu Y; Xu W; Zeng H
Redox Biol; 2018 Apr; 14():237-249. PubMed ID: 28965082
[TBL] [Abstract][Full Text] [Related]
6. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice].
Tan Q; Ren XY; Li J; Wang F; Deng SJ; Zeng HH
Ai Zheng; 2009 May; 28(5):472-7. PubMed ID: 19624873
[TBL] [Abstract][Full Text] [Related]
8. Novel mechanism of ethaselen in poorly differentiated colorectal RKO cell growth inhibition: Simultaneous regulation of TrxR transcription, expression and enzyme activity.
Yin H; Li J; Xiong K; Wang L; Wang T; Tan Q; Fu J; Ren X; Zeng H
Differentiation; 2011 Jan; 81(1):49-56. PubMed ID: 20864247
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo.
Xing F; Li S; Ge X; Wang C; Zeng H; Li D; Dong L
Oral Oncol; 2008 Oct; 44(10):963-9. PubMed ID: 18282784
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest.
Fu JN; Li J; Tan Q; Yin HW; Xiong K; Wang TY; Ren XY; Zeng HH
Invest New Drugs; 2011 Aug; 29(4):627-36. PubMed ID: 20195699
[TBL] [Abstract][Full Text] [Related]
11. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines.
Shi C; Yu L; Yang F; Yan J; Zeng H
Biochem Biophys Res Commun; 2003 Sep; 309(3):578-83. PubMed ID: 12963029
[TBL] [Abstract][Full Text] [Related]
12. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
Chen J; Li N; Liu B; Ling J; Yang W; Pang X; Li T
Life Sci; 2020 May; 248():117469. PubMed ID: 32109485
[TBL] [Abstract][Full Text] [Related]
13. Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model.
Ye SF; Li J; Ji SM; Zeng HH; Lu W
Acta Pharmacol Sin; 2017 Feb; 38(2):223-232. PubMed ID: 27917873
[TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation.
Zheng X; Zhang Y; Zhang L; Xu W; Ma W; Sun R; Zeng H
Biomed Pharmacother; 2016 Oct; 83():212-220. PubMed ID: 27372405
[TBL] [Abstract][Full Text] [Related]
15. [Induction of apoptosis in prostate cancer cell line PC-3 by BBSKE, a novel organoselenium compound, and its effect in vivo].
Shi CJ; Zeng HH; Li HW; Yang FG; Wu XQ; Yu LZ
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1984-8. PubMed ID: 14703435
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
Jiang Y; Feng X; Zheng L; Li SL; Ge XY; Zhang JG
Oncotarget; 2015 Sep; 6(28):25506-19. PubMed ID: 26325518
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of ethaselen and selenite treatment against A549 human non-small cell lung cancer cells.
Xu W; Ma WW; Zeng HH
Asian Pac J Cancer Prev; 2014; 15(17):7129-35. PubMed ID: 25227802
[TBL] [Abstract][Full Text] [Related]
18. The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway.
Lan L; Zhao F; Wang Y; Zeng H
Eur J Pharmacol; 2007 Jan; 555(2-3):83-92. PubMed ID: 17116300
[TBL] [Abstract][Full Text] [Related]
19. Glutathione reductase-mediated thiol oxidative stress suppresses metastasis of murine melanoma cells.
Li X; Wu J; Zhang X; Chen W
Free Radic Biol Med; 2018 Dec; 129():256-267. PubMed ID: 30086340
[TBL] [Abstract][Full Text] [Related]
20. Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy.
Wang L; Fu JN; Wang JY; Jin CJ; Ren XY; Tan Q; Li J; Yin HW; Xiong K; Wang TY; Liu XM; Zeng HH
Anticancer Drugs; 2011 Sep; 22(8):732-40. PubMed ID: 21562407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
